|
|
|
2011 Neurotech Leaders Forum
October 17-18, 2011
Radisson Hotel San Francisco Airport, Brisbane, CA
Tentative Agenda
Day One: Neurotechnology Fundamentals
The first day of the 2011 event is devoted to basic information about the neurotechnology industry, targeted at early-stage neurotechnology firms and research professionals contemplating launching a neurotech start-up. Conference faculty and industry panelists will offer a detailed background on the basics of the neurotechnolgy industry.
| 8:00-8:30 |
Registration and Coffee |
| 8:30-9:30 |
State of the Neurotechnology Industry: 2011
James Cavuoto, Editor and Publisher, Neurotech Reports
To open up this tenth anniversary event, Neurotech Business Report Editor James Cavuoto provides his insights and observations on the last decade in the neurotechnology industry. He surveys changes in the competitive landscape that have occured over the years, the most significant events of the last decade, and challenges confronting the industry in years ahead. |
| 9:30-10:00 |
Keynote Address: Neurotechnology and the NIH
Kip Ludwig, Ph.D., Program Director, Repair and Plasticity, National Institute of Neurological Disorders and Stroke, NIH
In his keynote address, Kip Ludwig, newly appointed program manager for repair and plasticity at the NIH National Institute of Neurological Disorders and Stroke, will offer attendees his views on his new role with the NIH and how it impacts the neurotechnology industry. |
| 10:00-10:30 |
Refreshment Break |
| 10:30-12:00 |
Neurotech Resimbursement Outlook: Impact of Health Care Reform
Thomas Hughes, Hughes and Associates
In this session, medical device reimbursement expert Thomas Hughes will offer his expertise on the impact of health care reform on reimbursement for neurotechnology devices. He will examine several aspects of the newly passed Affordable Care Act, including the Independent Payment Advisory Board, comparative effectiveness, and the medical device user fee tax. |
| 12:00-1:30 |
Luncheon
Presentation of 2011 Gold Electrode Awards |
| 1:30-3:00 |
Neurotechnology Entrepreneur Panel
James Cavuoto, Editor, Neurotech Reports, Moderator
Todd Langevin, President, Functional Neuromodulation, Inc.
Randy Nelson, CEO, Evergreen Medical Technology
Steven Stupp, Ph.D., President, Trigeminal Genomics
This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets.
|
| 3:00-3:30 |
Refreshment Break |
| 3:30-4:15 |
Advances in Implantable Neurotechnology Devices
James Cavuoto, Editor and Publisher, Neurotech Reports, Moderator
Don Deyo, Vice President, R&D, Medtronic Neuromodulation
Victor Pikov, Ph.D., Senior Scientist, Huntington Medical Research Institutes
In this session, leading experts in the field of implantable neuromodulation devices offer a look at new and forthcoming technology such as new electrode designs, advanced materials, and innovative pulse generation systems. |
| 4:15-5:00 |
The Investment Outlook for Neurotechnology
James Cavuoto, Editor, Neurotech Reports, Moderator
Heath Lukatch, Ph.D., Partner, Novo Ventures
Jonas Hansson, Associate, HealthCap
Paul Grand, Managing Director, RCT BioVentures
Mikhail Shapiro, Ph.D.,
Miller Fellow, UC Berkeley
In this session, venture capital professionals who track the neurotechnology industry will offer their insights on the current investment climate for neurotechnology startup firms. |
| 5:00-7:00 |
Cocktail Reception
|
| |
|
Day Two: New Applications of Neurotech
The second day of the conference offers an exclusive forum for neurotechnology executives and entrepreneurs to interact with investors, technologists, and potential partners who are working to expand the neurotech industry into new areas.
| 8:00:8:30 |
Registration and Coffee |
| 8:30-9:30 |
The Consumer Market for Neurotechnology
James Cavuoto, Editor and Publisher, Neurotech Reports
Alvaro Fernandez, CEO, SharpBrains
In this session, we explore the emerging consumer market for neurotechnology products. This includes applications of neurostimulation and neurosensing systems for market research, training, simulation, entertainment, and gaming. |
| 9:30-10:00 |
Consumer-Oriented Neural Interfaces
Victor Pikov, Ph.D., Senior Scientist, Huntington Medical Research Institutes
In this session, we look at some of the most exciting new consumer applications of neurotechnology to emerge in the last few years, as well as some novel applications on the horizon. |
| 10:00-10:30 |
Coffee Break
|
| 10:30-11:15 |
Advances in Neurosensing Technology
Kevin Wasserstein, Managing Director, Versant Ventures, Moderator
Andy Gotshalk, CEO, BlackRock NeuroMed
Micahel Russell, Ph.D., President, Aaken Insite, Inc.
In this session, we look at new technologies impacting the neurosensing industry, including new sensors, software, and imaging systems.
|
| 11:15-12:00 |
Noninvasive Neurostimulation Devices
Kevin Wasserstein, Managing Director, Versant Ventures, Moderator
Ting Lu, President, eNeura Therapeutics
Chip Wallace, President, Fisher-Wallace Laboratories
This session explores advances in noninvasive stimulation devices, including magnetic stimulation, transcranial AC and DC stimulation, and other new forms of stimulation. |
| 12:00-1:30 |
Luncheon |
| 1:30-2:15 |
Neurotechnology Entrepreneur Panel
James Cavuoto, Editor, Neurotech Reports, Moderator
David Westendorf, Vice President, Business Development, NeuroSky
Allen Braswell, CEO, Magneceutical Health
This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets. |
| 2:15-3:00 |
Advances in Neuromarketing Technology
Roger Quy, Ph.D., General Partner, Technology Partners, Moderator
Keith Winter, CEO, EmSense Corp.
Aaron Johnson, Director of Marketing, American Licorice Company
In this session, we look at new applications of neurotechnology in consumer marketing, market research, advertising, and product testing. |
| 3:00-3:30 |
Refreshment Break |
| 3:30-4:15 |
Panning for Gold: The Search for New Brain Biomarkers
James Cavuoto, Editor, Neurotech Reports, Moderator
Philip Low, Ph.D., CEO, NeuroVigil, Inc.
Steven Stupp, President, Trigeminal Neuromics
In this session, we explore the potential of discovering new EEG biomarkers as indicators of neurological disorders, cognitive states, or other physiological and psychological conditions. We also discuss the market potential for exploiting some of these new applications. |
| 4:15-5:00 |
Brave New World: Ethical Considerations of Neurotechnology
James Cavuoto, Editor, Neurotech Business Report, Moderator
Jennifer French, Executive Director, Neurotech Network
In this session, we examine some of the ethical and societal implications of new neurotechnology systems. Among the topics to be explored are limits on government control of noninvasive stimulation, informed consent, and performance enhancement. |
| 5:00-7:00 |
Cocktail Reception |
| |
|
|
